metoclopramide has been researched along with Hearing Loss, Sensorineural in 2 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Hearing Loss, Sensorineural: Hearing loss resulting from damage to the COCHLEA and the sensorineural elements which lie internally beyond the oval and round windows. These elements include the AUDITORY NERVE and its connections in the BRAINSTEM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buscaglia, J | 1 |
| Faris, J | 1 |
| Satar, B | 1 |
| Hidir, Y | 1 |
| Yetiser, S | 1 |
2 other studies available for metoclopramide and Hearing Loss, Sensorineural
| Article | Year |
|---|---|
Unsteady, unfocused, and unable to hear.
Topics: Adolescent; Cognition Disorders; Combined Modality Therapy; Female; Fluid Therapy; Gait Disorders, N | 2005 |
Effectiveness of hyperbaric oxygen therapy in idiopathic sudden hearing loss.
Topics: Adult; Aged; Aged, 80 and over; Audiometry, Pure-Tone; Chi-Square Distribution; Chlorpheniramine; Co | 2006 |